NL7608319A - Werkwijze ter bereiding van 1,2,3,4-tetrahydro- -isochinolinen, alsmede farmaceutische prepa- raten die deze verbindingen als actieve compo- nent bevatten. - Google Patents

Werkwijze ter bereiding van 1,2,3,4-tetrahydro- -isochinolinen, alsmede farmaceutische prepa- raten die deze verbindingen als actieve compo- nent bevatten.

Info

Publication number
NL7608319A
NL7608319A NL7608319A NL7608319A NL7608319A NL 7608319 A NL7608319 A NL 7608319A NL 7608319 A NL7608319 A NL 7608319A NL 7608319 A NL7608319 A NL 7608319A NL 7608319 A NL7608319 A NL 7608319A
Authority
NL
Netherlands
Prior art keywords
tetrahydroisoqueinolins
compounds
preparation
active component
pharmaceutical preparations
Prior art date
Application number
NL7608319A
Other languages
English (en)
Dutch (nl)
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of NL7608319A publication Critical patent/NL7608319A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • C07D257/06Five-membered rings with nitrogen atoms directly attached to the ring carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/121,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/1251,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C07D285/135Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NL7608319A 1975-07-28 1976-07-27 Werkwijze ter bereiding van 1,2,3,4-tetrahydro- -isochinolinen, alsmede farmaceutische prepa- raten die deze verbindingen als actieve compo- nent bevatten. NL7608319A (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB31570/75A GB1553230A (en) 1975-07-28 1975-07-28 1 - aminomethyl - 6,7-dihydroxy - 1,2,3,4-tetrahydroisoquinolines and the preparation thereof

Publications (1)

Publication Number Publication Date
NL7608319A true NL7608319A (nl) 1977-02-01

Family

ID=10325102

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7608319A NL7608319A (nl) 1975-07-28 1976-07-27 Werkwijze ter bereiding van 1,2,3,4-tetrahydro- -isochinolinen, alsmede farmaceutische prepa- raten die deze verbindingen als actieve compo- nent bevatten.

Country Status (19)

Country Link
US (1) US4096263A (es)
JP (1) JPS5217477A (es)
AR (1) AR212174A1 (es)
AT (1) AT358588B (es)
AU (1) AU506715B2 (es)
BE (1) BE844472A (es)
CA (1) CA1068276A (es)
CH (1) CH623310A5 (es)
DE (1) DE2633692A1 (es)
DK (1) DK143750C (es)
ES (1) ES450206A1 (es)
FR (1) FR2319357A1 (es)
GB (1) GB1553230A (es)
IE (1) IE43502B1 (es)
IT (1) IT1063405B (es)
MX (1) MX3999E (es)
NL (1) NL7608319A (es)
SE (1) SE423233B (es)
ZA (1) ZA764508B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5734275B2 (es) * 1973-07-30 1982-07-22
US4456757A (en) * 1981-03-20 1984-06-26 Asahi Kasei Kogyo Kabushiki Kaisha Isoquinolinesulfonyl derivatives and process for the preparation thereof
GB8921304D0 (en) * 1989-09-20 1989-11-08 Wyeth John & Brother Ltd New method of treatment and heterocyclic compounds used therein
JP4889463B2 (ja) * 2006-12-07 2012-03-07 株式会社椿本バルクシステム チェーンコンベヤ

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3389140A (en) * 1966-05-16 1968-06-18 Bristol Myers Co 1-beta-arylaminoethyl-2-methyl-6, 7-dimethoxy-1, 2, 3, 4-tetrahydroisoquinolines
JPS5734275B2 (es) * 1973-07-30 1982-07-22
US3963725A (en) * 1973-07-20 1976-06-15 Fujisawa Pharmaceutical Co., Ltd. 1,2,3,4-Tetrahydroisoquinoline derivatives and the preparation thereof
US3994891A (en) * 1974-12-20 1976-11-30 Armour Pharmaceutical Company Tetrahydroisoquinoline compounds

Also Published As

Publication number Publication date
AU506715B2 (en) 1980-01-24
DE2633692A1 (de) 1977-02-17
ES450206A1 (es) 1977-11-16
SE423233B (sv) 1982-04-26
ZA764508B (en) 1977-07-27
FR2319357B1 (es) 1978-11-17
CH623310A5 (es) 1981-05-29
DK143750B (da) 1981-10-05
GB1553230A (en) 1979-09-26
DK336676A (da) 1977-01-29
BE844472A (fr) 1977-01-24
IE43502L (en) 1977-01-28
AU1629076A (en) 1978-02-02
DK143750C (da) 1982-03-29
SE7608453L (sv) 1977-01-29
AT358588B (de) 1980-09-25
US4096263A (en) 1978-06-20
AR212174A1 (es) 1978-05-31
CA1068276A (en) 1979-12-18
ATA552076A (de) 1980-02-15
JPS5217477A (en) 1977-02-09
FR2319357A1 (fr) 1977-02-25
MX3999E (es) 1981-10-28
IE43502B1 (en) 1981-03-11
IT1063405B (it) 1985-02-11

Similar Documents

Publication Publication Date Title
NL7714329A (nl) Werkwijze ter bereiding van 3-de-0-methylforti- micinen alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
NL7708741A (nl) Werkwijze ter bereiding van prostaanzuurderiva- ten alsmede farmaceutische preparaten die deze derivaten als actieve component bevatten.
NL7507268A (nl) Werkwijze ter bereiding van 1(alpha),24-dihydroxy-chole- calciferolen, alsmede derivaten en voorlopers daar- van , alsmede farmaceutische preparaten die deze ver- bindingen als actieve componenten bevatten.
NL7702548A (nl) Werkwijze ter bereiding van 3,7-digesubstitueerde- -3-cefem-4-carbonzuurverbindingen, alsmede farma- ceutische preparaten die deze verbindingen als actieve component bevatten.
NL7700379A (nl) Werkwijze ter bereiding van anthracyclinegly- cosiden, alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
NL7614538A (nl) Werkwijze ter bereiding van farmacologisch actieve heterocyclische verbindingen en farmaceutische preparaten die deze verbindingen bevatten.
NL7706064A (nl) Werkwijze ter bereiding van heterocyclische verbindingen alsmede van farmaceutische pre- paraten die deze verbindingen als actieve component omvatten.
NL7713470A (nl) Werkwijze ter bereiding van 2-gesubstitueerde benzimidazoolverbindingen en de zuuradditiezou- ten daarvan alsmede farmaceutische preparaten die deze verbindingen als actieve component be- vatten.
NL7608496A (nl) Werkwijze ter bereiding van farmacologisch actieve verbindingen alsmede farmaceutische preparaten die deze verbindingen bevatten.
NL7610480A (nl) Werkwijze ter bereiding van hypolipemische ver- bindingen alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
NL7607337A (nl) Werkwijze ter bereiding van spirocycloalkyl- prostaanzuren en derivaten daarvan, alsmede geneeskundige preparaten die deze verbindingen als actieve component bevatten.
NL7604797A (nl) Werkwijze ter bereiding van nieuwe antibacteriele middelen alsmede preparaten die deze verbindingen als actieve component bevatten.
NL7609559A (nl) Werkwijze ter bereiding van oxazolidinonen alsmede geneeskrachtige middelen die deze ver- bindingen als actieve component bevatten.
NL7711414A (nl) Werkwijze ter bereiding van n-gesubstitueerde lactamen, alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
NL7708982A (nl) Werkwijze ter bereiding van dihydro-oxo-nicotine- zuren, alsmede farmaceutische preparaten die de- ze verbinding als actieve component bevatten.
NL7607975A (nl) Werkwijze ter bereiding van difenylsulfiden alsmede farmaceutische preparaten die deze verbindingen als actieve component omvatten.
NL7702180A (nl) Werkwijze ter bereiding van 9-gesubstitueerde- -8-azapurinen alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
NL7707150A (nl) Werkwijze ter bereiding van 2-lagere alkyl-7-ge- substitueerde-2 of 3-cefem-4-carbonzuurverbin- dingen, alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
NL7613041A (nl) Werkwijze ter bereiding van picolinezuurderiva- ten alsmede preparaten die deze verbindingen als actieve component omvatten.
NL7412302A (nl) Werkwijze ter bereiding van pyrazoliumverbindin- gen, alsmede herbicide preparaten die deze ver- bindingen als actieve component bevatten.
NL7714063A (nl) Werkwijze ter bereiding van imidazolinen alsmede pesticidepreparaten die deze verbindingen als actieve component bevatten.
NL7613334A (nl) Werkwijze ter bereiding van carbamaat-sulfenyl- -carbamoylfluorideverbindingen, alsmede pestici- de preparaten die deze verbindingen als actieve component omvatten.
NL7608319A (nl) Werkwijze ter bereiding van 1,2,3,4-tetrahydro- -isochinolinen, alsmede farmaceutische prepa- raten die deze verbindingen als actieve compo- nent bevatten.
NL7607494A (nl) Werkwijze ter bereiding van 2-benzopyranonderi- vaten alsmede geneeskundige preparaten die deze verbindingen als actieve component bevatten.
NL7513011A (nl) Werkwijze ter bereiding van 1,2,3,4-tetrahydroiso- chinolinen alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
A85 Still pending on 85-01-01
BV The patent application has lapsed